期刊文献+

Intermedin预处理对大鼠肾脏缺血再灌注损伤修复过程中细胞周期蛋白表达的影响 被引量:4

Effects of intermedin preconditioning on cyclin expression after renal ischemia-reperfusion in rats
原文传递
导出
摘要 目的观察Intermedin(IMD)预处理对大鼠肾脏缺血再灌注损伤(IRI)修复过程中细胞周期蛋白(cyclin)D1、cyclinE以及其依赖性激酶(CDKs)表达的影响,从而探讨IMD在这一过程中促进肾组织再生修复的作用机制。方法健康雄性Wistar大鼠共144只,体质量180-220g,随机分为对照组、IRI组、转空质粒组、转IMD组,每组36只。IRI组切除右肾后钝性分离左侧腹主动脉及肾动脉;转空质粒组、转IMD组大鼠切除右肾后,在六氟化硫微泡(声诺维)介导下将空质粒及IMD质粒转染入左肾;1周后分别制作肾脏IRI模型。每组于再灌注第1、2、3、4、7、14天时各取6只留取肾组织标本。检测各组肾组织中cyclinD1与CDK4,cyclinE与CDK2的表达。统计学处理采用单因素方差分析和t检验。结果IRI组cyclinD1、cyclinE以及CDK4.CDK2于再灌注后第1、2、3、4、7天表达逐渐增高,第7天时到达最高峰,第14天时仍有少量表达,与对照组比较差异有统计学意义(F值=54.92,69.60,61.28,77.38,P均〈0.05)。转IMD组上述指标在第1天即开始显著增高,第2、3、4、7天呈进行性下降,至第14天时恢复正常,与IRI组相比差异具有统计学意义(F值=54.92,69.60,61.28,77.38,P均〈0.05);转空质粒组与IRI组以上指标差异无统计学意义。结论IMD预处理在大鼠肾脏缺血再灌注损伤后早期能使cvclinDl、cyclinE以及CDK4、CDK2的表达明显上调,这一机制可能促进细胞周期进展从而加快肾组织再生修复。 Objective To observe the effect of intermedin (IMD) preconditioning on cyclin D1, cyclin E and CDKs expression, and explore its role in promoting kidney tissue regeneration after renal ischemia- reperfusion injury. Methods One hundred and forty-four healthy male Wistar rats were randomly divided into four groups: sham operation (S) group, ischemia-reperfusion injury (IR) group, empty plasmid (EP) group and IMD group. In the IR group, after the right kidney was excised, the aorta abdominalis and left renal artery were bluntly dissected in EP and IMD group, empty plasmid and IMD plasmid were transfected into the left kidney using ultrasound-micro-bubble (SonoVue) mediated system, respectively. One week later, renal IRI model was made by clasping the left renal artery for 45 min. After 1, 2, 3, 4, 7 and 14 day of reperfusion, the kidney in each group was collected to detect the expression of cyclin D1, cyclin E, CDK4 and CDK2 by western blot analysis or enzyme-linked immunosorbent assay (ELISA). Results Compared with S group, the expression of cyclin D1, cyclin E, CDK4 and CDK2 was significantly up-regulated in day 1, 2, 3, 4, 7 and 14 in IR group. And the above index increased gradually after repeffusion, and reached the peak at day 7 (F=54.92, 69.60, 51.28, 77.38, P〈0.05). While in IMD group, these indexes reached the peak at day 1, then progressively declined, and could not be detected at day 14 (compared with the IR group, F= 54.92, 69.60, 61.28, 77.38, P〈0.05). Conclusion IMD preconditioning can up-regulate the expression of cyclin D1, cyclin E, CDK2 and CDK4 in the early phase of renal ischemia-reperfusion injury that may accelerate repair of renal tissue, at least by, part~ by enhancinge cell proliferation.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2011年第8期541-545,共5页 Chinese Journal of Rheumatology
基金 基金项目:国家自然科学基金(30971380) 山西省农社科技攻关项目(20080311061-6)
关键词 再灌注损伤 细胞周期蛋白类 细胞周期蛋白质依赖激酶类 再生 肾脏 INTERMEDIN Reperfusion injury Cyclins Cyclin-dependent kinase Regeneration Kidney Intermedin
  • 相关文献

参考文献19

  • 1Taylor MM, Bagley SL, Samson WK. Intermedin/adrenome- dullin-2 acts within central nervous system to elevate blood pres- sure and inhibit food and water intake. Am J Physiol Regul Integr Comp Physiol, 2005, 288: 919-927.
  • 2Takei Y, Inoue K, Ogoshi M, et al. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett, 2004, 556: 53-58.
  • 3Takahashi K, Kikuchi K, Maruyama Y, et al. Immunocytochemi- eal localization of adrenomedullin 2/intermedin-like immunoreae- tivity in human hypothalamus, heart and kidney. Peptides, 2006, 27: 1383-1389.
  • 4寇敏,李荣山,周芸,乔晞,于桂花,邵珊,白波.大鼠肾脏缺血再灌注损伤中Intermedin及其受体表达的变化[J].医学研究杂志,2009,38(2):25-28. 被引量:8
  • 5于桂花,李荣山,乔晞,周芸,寇敏,王晨,白波,邵珊.大鼠肾脏缺血再灌注损伤中垂体中叶素及降钙素受体样受体的表达[J].中华肾脏病杂志,2009(5):387-391. 被引量:12
  • 6李宏,李荣山,乔晞,朱国贞,黄晓光,邵珊,白波.intermedin对大鼠肾脏缺血再灌注损伤的保护作用及其机制[J].中华肾脏病杂志,2010,26(8):614-618. 被引量:13
  • 7Hoehegger K, Koppelstaetter C, Tagwerker A, et al. p21 and mTERT are novel markers for determining different isehemic time periods in renal ischemia-reperfusion injury. Am J Physiol Rer- nal Physiol, 2007, 292: F762-F'/68.
  • 8Westhoff JH, Schildhom C, Jacobi C, et al. Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol, 2010, 21: 327-336.
  • 9Hunter T, Pines J. Cyclin D and CDK inhibitors come of age.Cell, 1994, 79: 547-550.
  • 10Kunduzova OR, Bianchi P, Pizzinat N, et al. Regulation of JNK/ ERK activation, call apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-repeffusion. FASEB J, 2002, 16: 1129-1131.

二级参考文献40

  • 1谢院生,陈香美.急性肾小管坏死后的修复与再生[J].中华肾脏病杂志,2006,22(11):658-660. 被引量:17
  • 2Yang JH, Qi YF, Jia YX, Pan CS,et al. Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts. Peptides. 2005 Mar;26(3) :501 -507
  • 3Sakata J,Shimokubo T, Kitamura K,et al. Molecular cloning and biological activities of rat adrenomedunin, a hypotensive peptide. Biochem Biophys Res Commun, 1993, 195(2): 921 -927
  • 4Lameire N,Van Biesen W,Vanholder R. Acute renal failure. Lancet, 2005,365 (9457) :417 - 430
  • 5Schrier RW,Wang W,Poole B,et al. Acute renal failure:definitions, diagonosis, pathogenesis, and therapy. J Clin Invest,2004,114 ( 1 ) :5 -14
  • 6Nishmatsu H, Hirata Y, Shindo T, et al. Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury:studies on transgenic/knockout mice of adrenomedullin gene[ J]. Circ Res,2002,90 ( 6 ) : 657 - 663
  • 7Roh J, Chang CL, Bhalla A,et al. Intermedin is a calcitonin/calcitonin gene - related peptidc family peptide acting through the ealcitonin receptor - like receptor/receptor activity - modifying protein receptor complexes. J Biol Chem ,2004,279( 8 ) :7264 - 7274
  • 8Takei Y, Inoue K, Ogoshi M, et al. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett,2004, 556(1 -3): 53-58
  • 9Yang JH, JiaYX, Pan CS,et al. Effects of intermedinl - 53 on cardiac function and ischemia/reperfusion injury in isolated rat hearts. Biochem Biophys Res Commun, 2005, 327(3):713 -719
  • 10Takahashi K, Kikucbi K, Maruyama Y, et al. Immunocytochemical localization of adrenomedullin 2/intermedin - like immunoreaetivity in human hypothalamus, heart and kidney. Peptides. 2006,27 (6) : 1383 - 1389

共引文献18

同被引文献51

  • 1林色奇,韩晶岩,刘红宁.芪参益气滴丸及其组成中药抗缺血再灌注损伤的研究进展[J].江西中医学院学报,2011,23(3):95-100. 被引量:10
  • 2于晓敏,刘新民,齐永芬,张志刚,唐朝枢.中介素1-53对油酸致大鼠急性肺损伤的保护作用[J].中华结核和呼吸杂志,2006,29(12):808-811. 被引量:21
  • 3Foord SM,Topp SD,Abramo M,et al.New methods for researching accessory proteins[J].J Mol Neurosci,2005,26:265-276.
  • 4Holmes D,Campbell M,Harbinson M,et al.Protective effects of intermedin on cardiovascular,pulmonary and renal diseases:comparison with adrenomedullin and CGRP[J].Curr Protein Pept Sci,2013,14:294-329.
  • 5Roh J,Chang CL,Bhalla A,et al.Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes[J].J Biol Chem,2004,279:7264-7274.
  • 6Takei Y,Inoue K,Ogoshi M,et al.Identification of novel adrenomedullin in mammals:a potent cardiovascular and renal regulator[J].FEBS Lett,2004,556:53-58.
  • 7Husmann K,Born W,Fischer JA,et al.Three receptoractivity-modifying proteins define calcitonin gene-related peptide or adrenomedullin selectivity of the mouse calcitoninlike receptor in COS-7 cells[J].Biochem Pharmacol,2003,66:2107-2115.
  • 8McLatchie LM,Fraser N J,Main MJ,et al.RAMPs regulate the transport and ligand specificity of the calcitonin-receptorlike receptor[J].Nature,1998,393:333-339.
  • 9Takahashi K,Kikuchi K,Maruyama Y,et al.Immunocytochemical localization of adrenomedullin2/intermedin-like immunoreactivity in human hypothalamus,heart and kidney[J].Peptides,2006,27:1383-1389.
  • 10Morimoto R,Satoh F,Murakami O,et al.Expression of adrenomedullin2/intermedin in human brain,heart,and kidney[J].Peptides,2007,28:1095-1103.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部